Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACADIA PHARMACEUTICALS INC Director's Dealing 2017

Mar 31, 2017

31237_dirs_2017-03-31_ecef6ad1-8e8f-4d5d-80ac-44dc10473fdc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2017-03-29

Reporting Person: YANG MICHAEL J. (N/A)